The patient¿s attorney alleged a deficiency against the device.
The product was used for therapeutic treatment of a ventral hernia.
It was reported that after the onlay implant, the patient experienced adhesions, recurrent drainage from midline wound, small bowel abscess, serosal tears, infection, desmoplastic reaction, purulent material, migrated mesh, non-healing wound, scarring, abdominal pain, recurrence, enterotomy, mesh erosion, and necrosis.
Post-operative patient treatment included revision surgery, hernia repair with sutures, resection of abdominal wall with excision of umbilicus, revision of mesh, removal of mesh, dissection of adhesions, repair of serosal tears, debridement of necrotic tissue/non-viable skin, hernia repair with new mesh, repair of small bowel enterotomy, lysis of adhesions, excision of mesh, component separation, wound closure of myocutaneous advancement flaps, and drainage of purulent material.
|